Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998
OBJECTIVES: To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2001-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2001/758483 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549510151143424 |
|---|---|
| author | Paul Rivest Terry N Tannenbaum |
| author_facet | Paul Rivest Terry N Tannenbaum |
| author_sort | Paul Rivest |
| collection | DOAJ |
| description | OBJECTIVES: To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy. |
| format | Article |
| id | doaj-art-4ff6c358796a4d65807d877616b23b65 |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 2001-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-4ff6c358796a4d65807d877616b23b652025-02-03T06:11:04ZengWileyCanadian Journal of Infectious Diseases1180-23322001-01-01122899210.1155/2001/758483Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998Paul Rivest0Terry N Tannenbaum1Direction de la santé publique, Régie régionale de la santé et des services sociaux de Montréal-Centre, CanadaDirection de la santé publique, Régie régionale de la santé et des services sociaux de Montréal-Centre, CanadaOBJECTIVES: To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy.http://dx.doi.org/10.1155/2001/758483 |
| spellingShingle | Paul Rivest Terry N Tannenbaum Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 Canadian Journal of Infectious Diseases |
| title | Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 |
| title_full | Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 |
| title_fullStr | Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 |
| title_full_unstemmed | Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 |
| title_short | Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 |
| title_sort | initial drug regimen for active tuberculosis cases in montreal 1995 1998 |
| url | http://dx.doi.org/10.1155/2001/758483 |
| work_keys_str_mv | AT paulrivest initialdrugregimenforactivetuberculosiscasesinmontreal19951998 AT terryntannenbaum initialdrugregimenforactivetuberculosiscasesinmontreal19951998 |